Percentage of patients, regardless of age, with a diagnosis of cancer who have undergone brachytherapy or external beam radiation therapy who have a treatment summary report in the chart that was communicated to the physician(s) providing continuing care and to the patient within one month of completing treatment
Information From 2015 Submission
Optimal End Stage Renal Disease (ESRD) Starts is the percentage of new adult ESRD patients during the measurement period who experience a planned start of renal replacement therapy by receiving a preemptive kidney transplant, by initiating home dialysis (peritoneal dialysis or home hemodialysis), or by initiating outpatient in-center hemodialysis via arteriovenous fistula or arteriovenous graft.
Type of score: Proportion
Percentage of patient visits for patients aged 21 years and older with a diagnosis of OA with an assessment for use of anti-inflammatory or analgesic OTC medications
Type of score: Proportion
Percentage of patient visits for patients aged 21 years and older with a diagnosis of osteoarthritis with assessment for function and pain
The percentage of women aged 55 years and older, or men, aged 50 years and older, who are taking chronic steroids (>/=3 months), and are taking drugs to prevent osteoporosis
The percentage of women, aged 55 and older, or men, aged 50 and older, with a diagnosis of osteoporosis who are taking osteoporosis therapy.
This measure assesses the proportion of all newborn infants who did not complete a hearing screen prior to discharge, who went on to receive an outpatient screen before the child was 31 days of age.
*Numbering within the parentheses references the US national extension quality measure identifiers developed for the Use Cases published in the Integrating the Healthcare Enterprise (IHE) Quality, Research and Public Health (QRPH) EHDI Technical Framework Supplement available at www.ihe.net/Technical_Framework/index.cfm#quality
The proportion of acute MI patients >= 18 years of age that receive "perfect care" based upon their eligibility for each performance measures
Percentage of patients, regardless of age, with a current diagnosis of Stage 0 through IIC melanoma or a history of melanoma of any stage, without signs or symptoms suggesting systemic spread, seen for an office visit during the one-year measurement period, for whom no diagnostic imaging studies were ordered
The quarterly incidence rate of falls amongst PACE participants per 1,000 participant days.